[go: up one dir, main page]

CU20100259A7 - PIRIMIDINE DERIVATIVES AS QUINASA INHIBITORS - Google Patents

PIRIMIDINE DERIVATIVES AS QUINASA INHIBITORS

Info

Publication number
CU20100259A7
CU20100259A7 CU20100259A CU20100259A CU20100259A7 CU 20100259 A7 CU20100259 A7 CU 20100259A7 CU 20100259 A CU20100259 A CU 20100259A CU 20100259 A CU20100259 A CU 20100259A CU 20100259 A7 CU20100259 A7 CU 20100259A7
Authority
CU
Cuba
Prior art keywords
derivatives
formula
quinasa
inhibitors
pirimidine derivatives
Prior art date
Application number
CU20100259A
Other languages
Spanish (es)
Other versions
CU23952B1 (en
Inventor
Kunyong Yang
Songchun Jiang
Christian Cho-Hua Lee
Xiaohui He
Bei Chen
Thomas H Marsilje Iii
Wenshuo Lu
Original Assignee
Irm Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/048428 external-priority patent/WO2010002655A2/en
Application filed by Irm Llc filed Critical Irm Llc
Publication of CU20100259A7 publication Critical patent/CU20100259A7/en
Publication of CU23952B1 publication Critical patent/CU23952B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención proporciona novedosos derivados de pirimidina de la fórmula 1: ESPACIO PARA LA FÓRMULA y composiciones farmacéuticas de los mismos, y métodos para utilizar estos compuestos. Por ejemplo, los derivados e pirimidina de la invención se pueden utilizar para tratar, aminorar o prevenir una condición que responda a la inhibición del factor de crecimiento tipo insulina (IGF-1R) o de la cinasa de linfoma anaplásico (ALK).The invention provides novel pyrimidine derivatives of the formula 1: SPACE FOR THE FORMULA and pharmaceutical compositions thereof, and methods for using these compounds. For example, the derivatives and pyrimidine of the invention can be used to treat, ameliorate or prevent a condition that responds to the inhibition of insulin-like growth factor (IGF-1R) or anaplastic lymphoma kinase (ALK).

CU2010000259A 2009-02-25 2010-12-23 PIRIMIDINE DERIVATIVES AS QUINASA INHIBITORS CU23952B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15543409P 2009-02-25 2009-02-25
PCT/US2009/048428 WO2010002655A2 (en) 2008-06-25 2009-06-24 Compounds and compositions as kinase inhibitors

Publications (2)

Publication Number Publication Date
CU20100259A7 true CU20100259A7 (en) 2011-11-15
CU23952B1 CU23952B1 (en) 2013-10-29

Family

ID=45000174

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2010000259A CU23952B1 (en) 2009-02-25 2010-12-23 PIRIMIDINE DERIVATIVES AS QUINASA INHIBITORS

Country Status (1)

Country Link
CU (1) CU23952B1 (en)

Also Published As

Publication number Publication date
CU23952B1 (en) 2013-10-29

Similar Documents

Publication Publication Date Title
CO6351787A2 (en) PIRIMIDINE DERIVATIVES AS CINASE INHIBITORS
MX2010002336A (en) Compounds and compositions as kinase inhibitors.
NI201100166A (en) BENZOFURANIL DERIVATIVES USED AS GLUCOKINASE INHIBITORS
SV2009003290A (en) COMPOUNDS AND COMPOSITIONS AS PROTEIN CINASE INHIBITORS
EA201100078A1 (en) DERIVATIVES OF PYRIMIDINE AS KINASE INHIBITORS
NI201100048A (en) AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS.
CR20140223A (en) NEW INHIBITING COMPOUNDS OF TYPE 10A PHOSPHODIESTERASE
CU23829B1 (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS
MX2012000711A (en) Pyrrolopyrazine inhibitors of kinases.
MX2012013197A (en) Indazole inhibitors of kinase.
UY33440A (en) ? PYRIMIDINYL COMPOUNDS FOR USE AS ATR INHIBITORS ?.
ECSP088450A (en) DERIVATIVES OF PYRIMIDINE 4- (3-AMINOPIRAZOL) FOR USE AS INHIBITORS OF THYROSINE KINASE IN CANCER TREATMENT
CL2012001391A1 (en) Substituted triazolopyridine derived compounds, mps-1 kinase inhibitors; pharmaceutical composition; preparation procedure; pharmaceutical combination and use for the prophylaxis or treatment of a hyperproliferative disease such as hematological, solid tumors and / or their metastases; intermediate compounds.
EA201101341A1 (en) KINASE INHIBITIVE COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEIR BASIS
UY33539A (en) ALK CHEMICAL COMPOUNDS
AR065721A1 (en) USED PIRIDAZINONE DERIVATIVES AS INHIBITORS OF GLUCANO SINTASA. PHARMACEUTICAL COMPOSITIONS.
NZ711376A (en) Heteroaryl compounds and uses thereof
UY32156A (en) SUBSTITUTED DERIVATIVES OF THE N2 - [1- (5 - FLUOROPIRIMIDIN -2-IL) ETIL] - N4 - (1-METHYL - 1H-IMIDAZOL - 4 - IL)) - PYRIMIDINE - 2,4 - DIAMINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS , PREPARATION PROCESS, COMPOSITIONS CONTAINING THEM AND APPLICATIONS.
CU20120002A7 (en) DERIVATIVES OF 1- (5,6-DIHYDROIMIDAZO (1,2-a) PIRAZIN-7 (8H) -IL) ETANONA
UY32529A (en) HETEROCYCLIC COMPOUNDS AND ITS USE AS INHIBITORS OF GLUCOGEN SYNTHEASE QUINASE 3
UY33238A (en) "Compounds as bradykinin-b1 antagonists"
ECSP078062A (en) 1,4-DIHYDROPIRIDINE-CONDENSED HETEROCICLES, PROCESSES TO PREPARE THE SAME, USE AND COMPOSITIONS CONTAINING THEM
EA201071224A1 (en) LIMK2 INHIBITORS, COMPOSITIONS CONTAINING THEM, AND METHODS OF THEIR USE
CU20100259A7 (en) PIRIMIDINE DERIVATIVES AS QUINASA INHIBITORS
TN2010000602A1 (en) Pyrimidine derivatives as kinase inhibitors

Legal Events

Date Code Title Description
FD Lapse (for not paying fees)